Recital 7, Commission Regulation (EC) No 847/2000 of 27 April 2000 laying down the provisions for i…

In forcesince 27 Apr 2000

In order to ensure appropriate respect of the market exclusivity provisions laid down in Article 8 of Regulation (EC) No 141/2000, it is necessary to lay down definitions of the concepts of "similar medicinal product" and "clinical superiority"; these definitions should take into account the work and experience of the Committee for Proprietary Medicinal Products in evaluating existing medicinal products, and the relevant opinions of the Scientific Committee on Medicinal Products and Medical Devices.